Doering, J., Hecker, M., Villeneuve, D., & Zhang, X. (2019). Adverse Outcome Pathway on aryl hydrocarbon receptor activation leading to early life stage mortality, via increased COX-2. OECD Publishing. https://doi.org/10.1787/bd46b538-en
Chicago Style (17th ed.) CitationDoering, Jon, Markus Hecker, Dan Villeneuve, and Xiaowei Zhang. Adverse Outcome Pathway on Aryl Hydrocarbon Receptor Activation Leading to Early Life Stage Mortality, via Increased COX-2. Paris: OECD Publishing, 2019. https://doi.org/10.1787/bd46b538-en.
MLA (9th ed.) CitationDoering, Jon, et al. Adverse Outcome Pathway on Aryl Hydrocarbon Receptor Activation Leading to Early Life Stage Mortality, via Increased COX-2. OECD Publishing, 2019. https://doi.org/10.1787/bd46b538-en.
Warning: These citations may not always be 100% accurate.